Kolmar Korea and Tego Science Make Strategic Alliance Agreement

Published: 2005-04-15 06:59:00

Updated: 2005-04-15 06:59:00

Kolmar Korea, a domestic subsidiary of multinational outsourcing services group specialized in the contract manufacturing, said it has made an agreement for strategic alliance with Tego Science Inc., which recently attained the market approval by the Korea Food and Drug Administration (KFDA) for ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK